IBIO
iBio, Inc.Company with tickers: IBIO
CIK
1420720
CUSIP
451033708
Shares Outstanding
49,678,561
13F Activity (30d)
32 filings
31 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $0 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $8,365,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Research & Development | $3,254,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Operating Income | $-8,365,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Net Income | $-7,730,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Basic) | $-0.06 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Diluted) | $-0.06 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |